Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Maclean

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|January 1, 1982
Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burdenJ Bray, G D MacLean, F J Dusel, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1987
The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapyJ R Hardy, G D Maclean, G A Foote, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccineG D MacLean, M A Reddish, R R Koganty, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1982
Preference of the early murine immune response for polymorphic determinants on human lymphoid-leukemia cells and the potential use of monoclonal antibodies to these determinants in leukemia-typing panelG D Maclean, T R Mosmann, J J Akabutu, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapyM A Reddish, G D MacLean, S Poppema, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|September 1, 1987
Cerebral metastases from epithelial ovarian carcinomaC E de Metz, A A Starreveld, G D MacLean, et al.
European Journal of Nuclear Medicine|April 1, 1997
Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II studyS A McQuarrie, G D MacLean, G R Boniface, et al.
Cancer Research|August 1, 1990
Analysis of human tumor associated Thomsen-Friedenreich antigenJ Samuel, A A Noujaim, G D MacLean, et al.
Journal of the National Cancer Institute|August 1, 1982
Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinantsG D MacLean, J Seehafer, A R Shaw, et al.
Cancer Investigation|January 1, 1994
Active specific immunotherapy against adenocarcinomasG D MacLean, M A Reddish, M B Bowen-Yacyshyn, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|January 1, 1982
Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burdenJ Bray, G D MacLean, F J Dusel, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1987
The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapyJ R Hardy, G D Maclean, G A Foote, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccineG D MacLean, M A Reddish, R R Koganty, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1982
Preference of the early murine immune response for polymorphic determinants on human lymphoid-leukemia cells and the potential use of monoclonal antibodies to these determinants in leukemia-typing panelG D Maclean, T R Mosmann, J J Akabutu, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1996
Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapyM A Reddish, G D MacLean, S Poppema, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|September 1, 1987
Cerebral metastases from epithelial ovarian carcinomaC E de Metz, A A Starreveld, G D MacLean, et al.
European Journal of Nuclear Medicine|April 1, 1997
Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II studyS A McQuarrie, G D MacLean, G R Boniface, et al.
Cancer Research|August 1, 1990
Analysis of human tumor associated Thomsen-Friedenreich antigenJ Samuel, A A Noujaim, G D MacLean, et al.
Journal of the National Cancer Institute|August 1, 1982
Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinantsG D MacLean, J Seehafer, A R Shaw, et al.
Cancer Investigation|January 1, 1994
Active specific immunotherapy against adenocarcinomasG D MacLean, M A Reddish, M B Bowen-Yacyshyn, et al.
Pageof 5